Estados Unidos - inglés - NLM (National Library of Medicine)

remedyrepack inc. - haloperidol decanoate (unii: ac20pj4101) (haloperidol - unii:j6292f8l3d) - haloperidol decanoate injection is indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy. since the pharmacologic and clinical actions of haloperidol decanoate injection are attributed to haloperidol as the active medication, contraindications, warnings, and additional information are those of haloperidol, modified only to reflect the prolonged action. haloperidol is contraindicated in patients with: - severe toxic central nervous system depression or comatose states from any cause. - hypersensitivity to this drug – hypersensitivity reactions have included anaphylactic reaction and angioedema (see warnings, hypersensitivity reactions and adverse reactions ). - parkinson's disease (see warnings, neurological adverse reactions in patients with parkinson's disease or dementia with lewy bodies ). - dementia with lewy bodies (see warnings, neurological adverse reactions in patients with

Australia - inglés - Department of Health (Therapeutic Goods Administration)

pathway international pty ltd - ubidecarenone -

Canadá - inglés - Health Canada

organon canada ltd ltee - nandrolone decanoate - liquid - 50mg - nandrolone decanoate 50mg - androgens

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

trion pharma ltd - ubidecarenone - oral solution - 5mg/1ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

trion pharma ltd - ubidecarenone - oral solution - 10mg/1ml

Emiratos Árabes Unidos - inglés - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

nandrolone decanoate -

Jordania - inglés - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع ادوية الصباغ - sabbagh drug store - nandrolone decanoate 50 mg/ml - 50 mg/ml

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - fluphenazine decanoate 100 mg/ml;   - solution for injection - 100 mg/ml - active: fluphenazine decanoate 100 mg/ml   excipient: sesame oil

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - fluphenazine decanoate 25 mg/ml;   - solution for injection - 25 mg/ml - active: fluphenazine decanoate 25 mg/ml  

Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - fluphenazine decanoate 100 mg/ml;   - injection (depot) - 50 mg/0.5ml - active: fluphenazine decanoate 100 mg/ml   excipient: sesame oil